European Association of Nuclear Medicine (EANM)’s Post

The Communications Working Group has crafted an updated introduction to #nuclearmedicine on Nuclear Medicine Europe's website. When searching for information about #radiopharmaceuticals, #isotopes, or #therapy, this page often appears as one of the first results regarding nuclear medicine for the general public. It was therefore essential to have up-to-date content, written and supervised by the leading experts in the industry. https://lnkd.in/dfsqrTWu #industry #patients #molecularimaging #imaging

Ready to cut the ribbon on your new industrial E-Beam or X-ray radiation processing facility? Wondering about the Synergies between Industrial Irradiation and Nuclear Medicine Isotope production? Both of those topics will be discussed in my presentations at the IMRP 2024 conference, Nov 3-8 in Costa Rica. Join me and many other leading industry experts! #imrp2024 #irradiation #nucmed

Check out the insights our VP of Radiopharmacy, Matt DeLong, offered about the impact of radiometals on the future of nuclear medicine.

Preparing to outfit your #NucMed department soon or in the future? Join an upcoming #webinar, where you’ll get a detailed look at our portfolio of products for your current and forthcoming Nuclear Medicine, Radiopharmacy and Theranostics needs. Learn about our safety-enhancing and efficiency-gaining solutions for physicians, technologists and physicists—from diagnostic tools like dose calibrators to #HealthPhysics radiation monitoring solutions to QA phantoms and more. Save your spot >> https://hubs.li/Q02HHxPs0

The 9th International Symposium on MEdical RADioisotopes (#ISMERAD2024) takes place on 26th of April 2024 in Ghent (NH Belfort). The main focus of this edition is on Alpha Therapy: New Approaches in Radionuclide Therapy. https://lnkd.in/end-VWEh Our goal is to: • Provide information on the perspectives of the world production of medical radioisotopes during the years to come; • Discuss challenges of the transport and distribution processes including safety, security, transparency and prompt delivery; • Present breakthroughs in radiopharmacy and nuclear medicine; • Introduce new industrial and research initiatives. Registration for the symposium is mandatory: https://lnkd.in/eYBgYNV5 #ISMERAD #MedicalRadioisotopes #AlphaTherapy #RadioisotopesSupplyChain

Seracam’s performance characterisation results have been published for the first time by our academic partners at Loughborough University: “The results of this work clearly demonstrate that for SFOV [small field of view] imaging, Seracam offers the potential to extend the utility of nuclear medicine investigations beyond the restraints of the larger fixed camera systems.” Congratulations to Sarah Bugby and the team on this important publication. The open access article is available here: https://lnkd.in/eNPgeUC7 Seracam® is for investigational use only and has not been cleared or approved by the FDA or UK and European regulatory authorities. #medicalimaging #diagnosticimaging #gammaimaging #hybridimaging #nuclearmedicine #molecularimaging

We are happy to promote another freshly published article, titled 'A scoping review of person-centred care strategies used in diagnostic Nuclear Medicine'. Many thanks to the EANM Technologists Committee for the hard work, and to the EFRS European Federation of Radiographer Societies for working on this paper with us. Read it now! ➡ https://lnkd.in/dadJTiAY #EANM #Publications #NuclearMedicine #Technologists

In the radiopharmaceutical area, producing radioactive tracers for nuclear medicine imaging #nuclearmedicine #radiotracer #radiopharmacy #medicalphysics

https://lnkd.in/dV66nDcZ Advancing medical diagnostics! The Nuclear Medicine Market, valued at USD 6.30 Billion in 2022, is set to soar with a projected 14.7% CAGR through 2029, reaching nearly USD 16.47 Billion. 🌐💉 #maximizemarketresearch #NuclearMedicine #MedicalDiagnostics #MarketGrowth

Yesterday we were delighted to participate in the Belgian EU Presidency Workshop: Securing Access to Radiopharmaceuticals for all European Patients during which Cristiana Gameiro was honored to present the innovative accelerators: pioneering technologies for advanced radioisotope production. This workshop featured very interesting presentations about radiopharmaceuticals' availability in Europe, regulatory framework and so inspiring patient testimonials treated by innovative radionuclide therapies. Is the Nuclear Medicine community in Europe ready for the future? Let's start the discussion in the comments! Belgian Presidency of the Council of the European Union 2024 #radiopharmaceuticals #radionuclide #cyclotron #EU2024BE